Clinical Review of Totally Implantable Venous Catheter

완전 거치형 정맥도관의 임상분석

  • Kim, Jung-Tae (Department of Thoracic and Cardiovascular Surgery, Kangbuk Samsung Hospital, Sungkyunkwan University College of Medicine) ;
  • Oh, Tae-Yoon (Department of Thoracic and Cardiovascular Surgery, Kangbuk Samsung Hospital, Sungkyunkwan University College of Medicine)
  • 김정태 (성균관대학교 의과대학 강북삼성병원 흉부외과학교실) ;
  • 오태윤 (성균관대학교 의과대학 강북삼성병원 흉부외과학교실)
  • Published : 2007.10.05

Abstract

Background: The introduction of central venous catheters in 1979 has aided the administration of chemotherapy to oncologic patients. We analyzed the clinical reviews and complications of totally implantable venous catheters in an effort to achieve optimal management. Material and Method: We retrospectively studied 100 cases with totally implantable venous catheter at our hospital and we report the results. Result: 100 totally implantable venous catheters were placed in the right subclavian vein in 74 cases (74%), the left subclavian vein in 21 cases, the right jugular vein in 3 cases, the left jugular vein in 1 case and the right femoral vein in 1 case. The immediate complications were 5 cases in malposition of the catheter and 5 cases of arterial puncture. The late complications were 1 case of subclavian vein thrombosis, which was treated with anticoagulation, and 2 cases of pinch-of syndrome. There were no other early or late complications. Conclusion: The low rate of complications in this study confirms the safety and convenience of using totally implantable venous catheter in patients undergoing prolonged chemotherapy. Yet because Infection, thrombosis, and catheter fracture are the most common long term complications of totally implantable venous catheters, early diagnosis and management of these problems can prevent severe complications.

배경: 중심정맥 도관은 1979년 처음 사용된 이래로 암환자의 치료에 있어 많은 편의를 제공하였다. 이에 본원 흉부외과에서는 완전 거치형 정맥도관의 임상 양상 및 사용에 따른 합병증 등을 분석하여 향후 치료에 도움이 되고자 본 연구를 하였다. 대상 및 방법: 2004년 11월부터 2006년 2월까지 완전 거치형 정맥도관 시술을 받은 100명의 환자를 대상으로 후향적 연구를 하여 다음과 같은 결과를 얻었다. 결과: 완전 거치형 정맥 도관 시술의 삽입정맥으로는 우측 쇄골하정맥 삽입이 74예(74%)였으며 좌측쇄골하 정맥(21예, 21%), 우측 경정맥(3예, 3%), 좌측 경정맥(1예, 1%)을 사용하였으며 1예에서는 우측 대퇴정맥을 사용하였다. 초기 합병증으로는 위치 이상이 5예(5%)와 동맥천자한 경우 5예 있었다. 만기 합병증으로는 쇄골하 정맥 혈전 형성이 한 예 있어 현재 항응고제 복용중이며 pinch off 증후군이 2예 있었다. 그 외의 초기 또는 만기 합병증은 없었다. 결론: 완전 거치형 도관의 사용은 합병증의 발생률은 낮고 비교적 안전한 방법이지만 감염, 혈전 형성, 도관의 절단 등은 장기간 사용시 나타날 수 있는 합병증으로 초기에 진단 및 치료가 된다면 더 큰 합병증을 예방할 수 있다.

Keywords

References

  1. Koch HJ, Pietsch M, Krause U, Wilke H, Eigler FW. Implantable vascular access system: experience in 1500 patients with totally implanted central venous port systems. World J Surg 1998:22;12-6 https://doi.org/10.1007/s002689900342
  2. Aitken DR, Catalano R, Minton JP. Central vein access in oncology patients: the 'peel-away' sheath for rapid insertion. J Surg Oncol 1983;22:81-3 https://doi.org/10.1002/jso.2930220204
  3. Ballarini C, Ceretti AP, Cordovana A, et al. Complications of subcutaneous infusion port in the general oncology population. Oncology 1999;56:97-102 https://doi.org/10.1159/000011947
  4. Barrios CH, Zuke JE, BlaesB, Hirsch JD, Lyss AP. Evaluation of an implantable venous access system in a general oncology population. Oncology 1992;49:474-8 https://doi.org/10.1159/000227095
  5. Hinke DH, Zandt-Stastny DA, Goodman LR, et al. Pinch-off syndrome: a complication of implantable subclavian venous access devices. Radiology 1990;177:353-6 https://doi.org/10.1148/radiology.177.2.2217768
  6. Brothers TE, Von Moll LK, Niederhuber JE, Roberts JA, Walker-Andrew S, Ensminger WD. Experience with subcutaneous infusion ports in three hundred patients. Surg Gynecol Obstet 1988;166:295-301
  7. Salzman MB, Rubin LG. Intravenous catheter related infections. Adv Pediatr Infect Dis 1995;10:337-42
  8. Sariego J, Bootorabi B, Matsumoto T, Kerstein M. Major long term complications in 1,422 permanent venous access devices. Am J Surg 1993;165:249-51 https://doi.org/10.1016/S0002-9610(05)80520-3
  9. Vlasveld LT, Rodenhuis S, Rutgers EJTh, et al. Catheter related complications in 52 patients treated with continuous infusion of low dose recombinant interleukin-2 via an implanted central venous catheter. Eur J Surg Onco 1994;20:122-9
  10. Raad II, Luna M, Khalil SM, Costerton JW, Lam C, Bodey GP. The relationship between thrombotic and infectious complications of central venous catheters. JAMA 1994;271:1014-6 https://doi.org/10.1001/jama.271.4.271
  11. Bern MM, Lokich JJ, Wallach SR. Very low doses of wafarin can prevent thrombosis in central venous catheters: a randomized prospective trial. Ann Intern Med 1990;112:423-7 https://doi.org/10.7326/0003-4819-76-3-112-6-423